Difficulty: Medium
Average Score: 84%
Practice
In which of the following conditions centrally acting anticholinergic drugs cannot be used for treatment?
Correct answer
C
Rationale
In pharmacology of CNS drugs, understanding the appropriate use of centrally acting anticholinergic drugs is crucial for effective patient care. In this scenario, the correct answer is C) Tardive dyskinesia. Centrally acting anticholinergic drugs are contraindicated in tardive dyskinesia due to the risk of exacerbating the symptoms. Tardive dyskinesia is characterized by involuntary, repetitive movements, often involving the face and tongue, which can be worsened by anticholinergic medications.
Option A) Parkinsonian disease is a condition where centrally acting anticholinergic drugs can be used as part of the treatment to help manage the symptoms of tremors and rigidity associated with Parkinson's disease. These drugs can help balance the neurotransmitters involved in motor control.
Option B) Akathisia, a movement disorder characterized by a feeling of inner restlessness and a compelling need to move, can also be managed with centrally acting anticholinergic drugs. These medications can help alleviate the symptoms associated with akathisia by modulating neurotransmitter activity.
Educationally, it is important for healthcare providers to be aware of the specific indications and contraindications of CNS drugs to ensure safe and effective treatment. Understanding the unique characteristics of each condition and how medications interact with the CNS is essential for making informed clinical decisions. By grasping these concepts, healthcare professionals can optimize patient care and minimize potential risks associated with pharmacological interventions.
Option A) Parkinsonian disease is a condition where centrally acting anticholinergic drugs can be used as part of the treatment to help manage the symptoms of tremors and rigidity associated with Parkinson's disease. These drugs can help balance the neurotransmitters involved in motor control.
Option B) Akathisia, a movement disorder characterized by a feeling of inner restlessness and a compelling need to move, can also be managed with centrally acting anticholinergic drugs. These medications can help alleviate the symptoms associated with akathisia by modulating neurotransmitter activity.
Educationally, it is important for healthcare providers to be aware of the specific indications and contraindications of CNS drugs to ensure safe and effective treatment. Understanding the unique characteristics of each condition and how medications interact with the CNS is essential for making informed clinical decisions. By grasping these concepts, healthcare professionals can optimize patient care and minimize potential risks associated with pharmacological interventions.